CHE vs PODD · P/E 24, rev $2.43B vs P/E 34, rev $2.07B
Chemed Corp (CHE) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CHE and PODD stock pages for the full models.
Not investment advice.